Insights_subhead

    Government programs

April 26, 2016 | Cathy Starner

Can alerts at the pharmacy counter help curb opioid use?

Opioid misuse has emerged as an epidemic. The Centers for Medicare and Medicaid Services has implemented an opioid overutilization monitoring system. But is it enough? My team and I recently explored whether additional opportunity to curb opioid use existed. 

What we learned | Study poster


Nov. 25, 2015 | Prime Therapeutics

Pilot study proves value of high-risk medicine interventions for Medicare beneficiaries

Health care spend among U.S. seniors is wildly disproportionate. At 13 percent, those ages 65 and older make up a small segment of the population. Yet they account for more than one-third of all health care costs — spending at a rate three times that of the average working-age person.

Study analysis


Nov. 5, 2015 | Cathy Starner

Engaging Medicare members improves adherence, can lead to higher Star ratings

To learn how MTM programs impact adherence — and eventually Star ratings — our team of researchers analyzed pharmacy claims data for 1.2 million Medicare members. We compared adherence between qualified members who engaged in MTM* vs. those who did not within the three drug adherence Star ratings  categories: diabetes, statins and renin angiotensin system (RAS) antagonists.

Study analysis


June 9, 2014 | Prime Therapeutics

Prime’s insights take an international stage

Passports in hand, Prime’s clinical researchers departed last week for the 19th annual meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Prime’s team presented two studies, offering new insights on the important topics of specialty pharmacy costs and medication adherence:

  • Understanding the pharmacy costs related to treating breast cancer
  • Assessing the impact of provider mailings on medication adherence in the Medicare Part D population

Event recap